ALBO
Albireo Pharma, Inc. Common Stock
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
109 hedge funds and large institutions have $495M invested in Albireo Pharma, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 30 increasing their positions, 39 reducing their positions, and 8 closing their positions.
Holders
109
Holders Change
+13
Holders Change %
+13.54%
% of All Funds
1.73%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.06%
New
21
Increased
30
Reduced
39
Closed
8
Calls
$8.42M
Puts
$486K
Net Calls
+$7.93M
Net Calls Change
+$6.83M
Top Buyers
Top Sellers
1 |
AG
1
Artal Group
Luxembourg
|
$0 |
2 |
2
Millennium Management
New York
|
$1.82M |
3 |
3
Goldman Sachs
New York
|
$1.29M |
4 |
![]()
4
Marshall Wace
London,
United Kingdom
|
$0 |
5 |
5
State Street
Boston,
Massachusetts
|
$27.1M |